Vivos TherapeuticsInc Debt to Equity vs. Total Debt

VVOS Stock  USD 4.65  0.18  4.03%   
Based on the measurements of profitability obtained from Vivos TherapeuticsInc's financial statements, Vivos TherapeuticsInc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess Vivos TherapeuticsInc's ability to earn profits and add value for shareholders. Price To Sales Ratio is likely to drop to 0.63 in 2024. Operating Cash Flow Sales Ratio is likely to drop to -1.48 in 2024. At this time, Vivos TherapeuticsInc's Interest Income is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 3.8 M in 2024, whereas Accumulated Other Comprehensive Income is likely to drop (1.4 M) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.80.72
Moderately Up
Pretty Stable
For Vivos TherapeuticsInc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vivos TherapeuticsInc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vivos TherapeuticsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vivos TherapeuticsInc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vivos TherapeuticsInc over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.19)
Revenue Per Share
12.635
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.84)
Return On Equity
(3.11)
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vivos TherapeuticsInc Total Debt vs. Debt to Equity Fundamental Analysis

Vivos Total Debt vs. Debt to Equity

Vivos TherapeuticsInc

 = 
null
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Vivos TherapeuticsInc

Total Debt

 = 

Bonds

+

Notes

 = 
2.41 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Vivos Total Debt vs Competition

Vivos TherapeuticsInc is rated below average in total debt category among related companies. Total debt of Health Care industry is at this time estimated at about 39.76 Billion. Vivos TherapeuticsInc adds roughly 2.41 Million in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Workforce  Valuation  Capitalization  Revenue

Use Vivos TherapeuticsInc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vivos TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.

Vivos TherapeuticsInc Pair Trading

Vivos TherapeuticsInc Pair Trading Analysis

The ability to find closely correlated positions to Vivos TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vivos TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vivos TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vivos TherapeuticsInc to buy it.
The correlation of Vivos TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vivos TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vivos TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vivos TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vivos TherapeuticsInc position

In addition to having Vivos TherapeuticsInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Books Thematic Idea Now

Books
Books Theme
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports:
Check out World Market Map.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Vivos Stock analysis

When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
To fully project Vivos TherapeuticsInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vivos TherapeuticsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vivos TherapeuticsInc's income statement, its balance sheet, and the statement of cash flows.
Potential Vivos TherapeuticsInc investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vivos TherapeuticsInc investors may work on each financial statement separately, they are all related. The changes in Vivos TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vivos TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.